Paricalcitol

규격

131918-61-1CAS 번호

658-064-6EC 번호

trans-(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diolIUPAC 명칭

C27H44O3화학식

416.6 g/mol분자량

Paricalcitol; 131918-61-1; Zemplar; Compound 49510; 19-Nor-1alpha,25-dihydroxyvitamin D2; Compound-49510; 19-Nor-1,25-(OH)2D2; DTXSID4048640; (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol; (7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1alpha,3beta,25-triol; 6702D36OG5; CHEBI:7931; (1R,3R,7E)-17beta-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9,10-secoestra-5,7-diene-1,3-diol; DTXCID7028566; paricalcitolum; (1R,3R)-5-((2E)-2-((1R,3aS,7aR)-1-((E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol; (1R,3R,7E)-17beta-((2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-9,10-secoestra-5,7-diene-1,3-diol; RefChem:56862; H05BX02; Paracalcin; (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol; NCGC00182706-01; Paricalcitol [USAN]; Zemplar (TN); 19-Nor-1-alpha,25-dihydroxyvitamin D2; HSDB 7360; (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol; 1884139-61-0; Paricalcitol [USAN:USP:INN]; UNII-6702D36OG5; ABT-358; Paricalcitol (Standard); PARICALCITOL [MI]; PARICALCITOL [JAN]; (1alpha.3beta,7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol; PARICALCITOL [HSDB]; SCHEMBL3655; PARICALCITOL [VANDF]; PARICALCITOL [MART.]; BIDD:GT0330; PARICALCITOL [USP-RS]; PARICALCITOL [WHO-DD]; Paricalcitol (JAN/USP/INN); GTPL2791; orb1296135; orb3141002; CHEMBL1200622; BDBM233195; PARICALCITOL [ORANGE BOOK]; PARICALCITOL [USP IMPURITY]; EX-A4434; PARICALCITOL [USP MONOGRAPH]; Tox21_112987; EBC-13071; HY-50919R; LMST04030163; s6681; AKOS005145562; CS-0705; DB00910; FP26765; 19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol, (1alpha,3beta,7E,22E)-; (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,1R,4S)-5-hydroxy-1,4,5-trimethyl-hex-2-enyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol; HY-50919; MS-27260; CAS-131918-61-1; C08127; D00930; Q155746; 19-Nor-1alpha,25-dihydroxyvitamin D2; Paricalcitol; BRD-K60585088-001-01-5; (1a,3b,7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol; (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-Hydroxy; (1.ALPHA.3.BETA.,7E,22E)-19-NOR-9,10-SECOERGOSTA-5,7,22-TRIENE-1,3,25-TRIOL; (7E,22E)-19-NOR-9,10-SECOERGOSTA-5,7,22-TRIENE-1.ALPHA.,3.BETA.,25-TRIOL; 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3R,5Z)-동의어